We found significant associations between CRABP1 immunoreactivity and poor prognosis (Fisher’s exact test, p = 0.006 for grade and p = 0.008 for survival status) (Figures 6E, F); however, we did not observe any significant difference in tumor stage (Fisher’s exact test, p = 0.205, Figure S13B). The gene discussed is CRABP1; the disease is neoplasm.